-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704.O1.6 704. Immunotherapies: Therapeutic T cell Manipulation

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, Adult, ALL, AML, CRS, Leukemia, Diseases, neurotoxicity, Non-Biological, CAR-Ts, Therapies, Mantle Cell Lymphoma, Adverse Events, Non-Hodgkin Lymphoma, B-Cell Lymphoma, DLBCL, immunotherapy, Lymphoid Malignancies, Study Population, Myeloid Malignancies, Clinically relevant, transplantation
Monday, December 7, 2020: 1:30 PM-3:00 PM
Moderators:
Matthew J Frigault, MD, MSc, Massachusetts General Hospital and Rayne H. Rouce, MD, Clinical Care Center-Texas Children's Hospital
Disclosures:
Rouce: Tessa Therapeutics: Other, Research Funding; Novartis: Honoraria.
1:30 PM

John H. Baird, MD1,2, Matthew J. Frank, MD, PhD1,2, Juliana Craig, BA1*, Shabnum Patel, PhD3*, Jay Y. Spiegel, MD, FRCPC1,2, Bita Sahaf, PhD1*, Sheren F. Younes, MD, PhD4*, Jean S. Oak, MD, PhD5*, Yasodha Natkunam, MD, PhD5, Zachary Ehlinger, MS3*, Warren D. Reynolds, BS3*, Sally Arai, MD, MS2, Laura J. Johnston, MD2, Robert Lowsky, MD, FRCP2, Robert S. Negrin, MD6, Andrew R. Rezvani, MD2, Parveen Shiraz, MD2,3, Surbhi Sidana, MD3,6, Wen-Kai Weng, MD, PhD2, Liora M. Schultz, MD7, Sneha Ramakrishna, MD8, Kara L Davis, DO9, Steven A. Feldman, PhD3*, Crystal L. Mackall, MD1,10, David B. Miklos, MD, PhD2,11 and Lori Muffly, MD, MS1,12

1Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
2Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA
3Center for Cancer Cell Therapy, Stanford University, Stanford, CA
4Department of Pathology, Stanford University School of Medicine, Stanford, CA
5Department of Pathology, Stanford University Medical Center, Stanford, CA
6Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA
7Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA
8Stanford University School of Medicine, Department of Pediatrics, Division of Hematology and Oncology, Palo Alto, CA
9Division of Hematology, Oncology and Stem Cell Transplant, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
10Department of Pediatrics, Division of Hematology and Oncology, Stanford University, Stanford, CA
11Stanford University School of Medicine, Stanford, CA
12Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA

1:45 PM

Arushi Khurana, MBBS1, Matthew A Hathcock2*, Thomas M. Habermann, MD1, Abdullah S. Al Saleh, MBBS3, Sangeetha Gandhi, MBBS1*, Tuan A Truong2*, Nabila Nora Bennani, MD2, Jonas Paludo, MD1, Jose C Villasboas, MD2, Stephen M. Ansell, MD, PhD4, David J. Inwards, MD1, Luis F. Porrata, MD1, Patrick B. Johnston, MD/ PhD2, Ivana Micallef, MD1 and Yi Lin, MD, PhD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
3Mayo Clinic Rochester, Division of Hematology, Rochester, MN
4Mayo Clinic, Rochester, MN

2:00 PM

Paolo F Caimi, MD1, Ashish Sharma2*, Patricio Rojas, MD3*, Seema Patel, PharmD4*, Jane Reese1,2*, Folashade Otegbeye, MBBChir, MPH1, Andrew Worden5*, Michael Kadan5*, Michael Maschan, MD, PhD6, Rimas J Orentas, PhD7, Boro Dropulic, PhD, MBA5*, Rafick Sekaly8* and Marcos de Lima, MD1

1Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
2Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
3Pontificia Universidad Catolica de Chile, Santiago, CHL
4Adult Hematologic Malignancies & Stem Cell Transplant Program, University Hospitals Seidman Cancer Center, Cleveland, OH
5Lentigen Technology Inc., A Miltenyi Biotec Company, Gaithersburg, MD
6Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation
7Pediatrics, University of Washington School of Medicine, Seattle, WA
8Case Western Reserve University, Cleveland, OH

2:15 PM

Monzr M. Al Malki, MD1, Miguel-Angel Perales, MD2, Dipenkumar Modi, MD3, Sumithira Vasu, MD, MBBS4, Megan Nelson, RN5*, Donna Bui6*, Sojung Kim7*, Ruipeng Wang7*, Emily Lu7*, Mathias Oelke7*, Han Myint, MD, FRCPath, FRCP7 and Juan C. Varela, MD, PhD8

1Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
2Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI
4The Ohio State University, Columbus, OH
5Advent Health Cancer Institute, Orlando, FL
6City Of Hope, Duarte,, CA
7Neximmune Inc, Gaithersberg, MD
8Blood and Marrow Transplant Center, Florida Hospital, WINTER PARK, FL

2:30 PM

Tyce J Kearl, MD, PhD1,2,3, Ao Mei4*, Ryan Brown5*, Bryon Johnson, PhD1,3,4, Dina Schneider, PhD6, Boro Dropulic, PhD, MBA6*, Parameswaran Hari, MBBS, MD7, Nirav N. Shah, MD3 and Subramaniam Malarkannan, PhD1,2,3,4*

1Division of Hematology, Oncology and Bone Marrow Transplantation, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
2Blood Research Institute, Versiti, Milwaukee, WI
3Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
4Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI
5Medical Scientist Training Program, Medical College of Wisconsin, Milwaukee, WI
6Lentigen Technology, Inc., a Miltenyi Biotec Company, Gaithersburg, MD
7Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Brookfield, WI

2:45 PM

Chiara F Magnani1*, Giuseppe Gaipa, PhD2,3, Federico Lussana, MD4*, Daniela Belotti3,5*, Giuseppe Gritti, MD, PhD4*, Sara Napolitano, MD6*, Chiara Buracchi, PhD2*, Gian Maria Borleri4*, Silvia Zaninelli7*, Giuliana Rizzuto4*, Sarah Tettamanti, PhD2*, Valentina Colombo2,3*, Giovanni Cazzaniga, PhD2, Benedetta Cabiati2,3*, Attilio Rovelli, MD6*, Ettore Biagi, MD, PhD2,6*, Stefania Galimberti, PhD8*, Fabrizio Benedicenti9*, Eugenio Montini, PhD9*, Silvia Ferrari, MD4*, Martino Introna, MD4,7, Adriana Balduzzi, MD5,6, Maria Grazia Valsecchi, PhD8*, Giuseppe Dastoli, MD2*, Alessandro Rambaldi, MD4,10 and Andrea Biondi, MD2,3,6

1Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicoc, Monza, Italy
2Tettamanti Research Center, Department of Pediatrics, University of Milano - Bicocca/Fondazione MBBM, Monza, Italy
3Laboratorio di Terapia Cellulare e Genica Stefano Verri, ASST-Monza, Ospedale San Gerardo, Monza, Italy
4Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
5Department of Pediatrics, University of Milano - Bicocca, Milan, Italy
6Clinica Pediatrica Università Milano - Bicocca/Fondazione MBBM, Monza, Italy
7USS Centro di Terapia Cellulare "G. Lanzani", Bergamo, Italy
8Bicocca Bioinformatics, Biostatistics and Bioimaging Centre, Department of Medicine and Surgery, University of Milano - Bicocca, Monza, Italy
9San Raffaele Telethon Institute for Gene Therapy (SR-TIGET) / IRCCS San Raffaele Scientific Institute, Milan, Italy
10Department of Oncology and Hematology, University of Milan, Milan, Italy

*signifies non-member of ASH